Drawing for SIMCELL

USPTO serial 79340855

SIMCELL

Reviewed by CopyMark Law Group

Reg. 7272903Status 790Registered
Filing date
Status date
Registration date
Jan 16, 2024
Examiner
O'BRIEN, JENNIFER LYNN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with SIMCELL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Scott J. Major

OXFORD SIMCELL LIMITEDCENTRE FOR INNOVATION AND ENTERPRISE,BEGBROKE SCIENCE PARK BEGBROKEOXFORDSHIRE OX5 1PF,

Goods and services

ClassDescriptionStatusFirst use
001Biological preparations for use in industry and science; cells for research and scientific purposes; cell culture reagents for scientific and research use; bacterial preparations, other than for medical and veterinary use; bacteriological preparations, other than for medical and veterinary use in the nature of biological preparations for use in industry and science; biological preparation for use in cell cultures, other than for medical or veterinary use; biological tissue cultures, other than for medical and veterinary useACTIVE—
005Pharmaceuticals, medical and veterinary preparations, namely, pharmaceutical and medical preparations for the treatment and prevention of infectious diseases, cancers, metabolic diseases, and neurological diseases; cells for medical and veterinary use; bacterial preparations for medical and veterinary use; bacteriological preparations for medical and veterinary use; biological preparations for medical and veterinary use for the treatment and prevention of infectious diseases, cancers, metabolic diseases, and neurological diseases; biological tissue cultures for medical and veterinary use; biological tissue cultures of microorganisms for medical and veterinary use; diagnostic preparations and materials, namely diagnostic reagents for veterinary, medical and clinical medical use, diagnostic substances for medical purposes, diagnostic preparations for pharmaceutical use, diagnostic biomarker reagents for medical and veterinary purposes, diagnostic reagents for medical and veterinary use in in vivo and in vitro diagnosis, and diagnostic reagents for veterinary, medical and clinical medical use in the nature of biological markers for therapeutic or diagnostic use; diagnostic preparations for medical and veterinary purposes; in vitro diagnostic preparations for medical useACTIVE—
042Scientific and technological services, namely, scientific research, analysis, testing, scientific research advisory, technological advisory, advisory on scientific and technological research in the field of manufacturing processes and consultancy services in the field of microorganisms and cells, and bacterial therapy, and research and design relating thereto; scientific research; scientific analysis in the field of microorganisms and cells, and bacterial therapy; technical data analysis services, namely, technical research in the field of microorganisms and cells, and bacterial therapy; research and development in the field of microorganisms and cells; biological research; bacteriological research; scientific services in the nature of cell culture services for scientific and research purposes, for others relating to the isolation and cultivation of human cells; cell culture services for scientific and research purposes for others; cell culture services for scientific and research purposes for others, namely, cell separation research and cell separation technology research services; research and development in the field of bacterial therapy; design and development of medical diagnostic testing apparatus and reagents; scientific laboratory testing services; information, advice and consultancy services relating to the aforementionedACTIVE—
044Medical services; veterinary services; medical treatment services, namely, care for patients with, and prevention of, diseases using non-replicating cells; medical services relating to the treatment and processing of human cells; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical therapy services, namely, nutritional therapy services, stem cell therapy services, bacterial therapy services, intravenous therapy services, hormone therapy services, immunotherapy services, therapy for disease prevention and vaccine therapy services; medical analysis services relating to the treatment of persons, namely, analysis of human tissues for the purposes of medical care and disease prevention; diagnostic testing services, namely, medical, genetic and veterinary testing, for diagnostic or medical treatment purposes; diagnostic testing relating to human health, namely, medical and genetic testing for diagnostic or medical treatment purposes; information, advice and consultancy services relating to the aforementionedACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 18, 2026PETCCANCELLATION INSTITUTED NO. 999999—
May 7, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 17, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 17, 2024FIMPFINAL DISPOSITION PROCESSED—
Apr 16, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 22, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 16, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 16, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 12, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Oct 31, 2023GPNXNOTIFICATION PROCESSED BY IB—
Oct 31, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 31, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 25, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 25, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Oct 11, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 11, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 11, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 28, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 5, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 5, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 5, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Aug 7, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 7, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 7, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 14, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 13, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 13, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 15, 2023RFNTREFUSAL PROCESSED BY IB—
Dec 27, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 27, 2022RFRRREFUSAL PROCESSED BY MPU—
Oct 30, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 29, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 24, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 20, 2022DOCKASSIGNED TO EXAMINER—
May 24, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
May 20, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 19, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance